<DOC>
	<DOCNO>NCT01638325</DOCNO>
	<brief_summary>BC106 molecule inject insulin lispro may change speed absorption insulin lispro . The purpose study evaluate safety BC106 insulin lispro side effect might associate , blood level insulin lispro injection skin BC106 insulin lispro affect blood sugar injection skin . There minimum 7 day washout single dos .</brief_summary>
	<brief_title>A Study Insulin Lispro With BioChaperone Excipient Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Are childbearing potential Have body mass index ( BMI ) 18 29.9 kilogram per square meter ( kg/m^2 ) , inclusive Are nonsmoker smoke least 6 month prior enter study Have fast plasma glucose le 6.0 millimoles per liter ( mmol/L ) screening Have know allergy insulin excipients , relate drug , history relevant allergic reaction origin include allergy dextrans Have history firstdegree relative know diabetes mellitus Have use systemic glucocorticoid within 3 month prior entry study Have donate blood loss 450 milliliter ( mL ) 3 month prior study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>